We are live on ! Find out more
PMC

PharMerica Corporation
PMC

Delisted

PMC was delisted on the 7th of December, 2017.

Back to rankings

158 hedge funds and large institutions have $627M invested in PharMerica Corporation in 2013 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 59 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 14

67% more capital invested

Capital invested by funds: $375M → $627M (+$252M)

7% more funds holding

Funds holding: 147 → 158 (+11)

10% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 59

24% less call options, than puts

Call options by funds: $492K | Put options by funds: $645K

Holders
158
Holders Change
+11
Holders Change %
+7.48%
% of All Funds
4.59%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
25
Increased
53
Reduced
59
Closed
14
Calls
$492K
Puts
$645K
Net Calls
-$153K
Net Calls Change
-$159K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.8M
2
SFM
Systematic Financial Management
New Jersey
+$9.77M
3
TAM
THB Asset Management
Connecticut
+$6.33M
4
Ameriprise
Ameriprise
Minnesota
+$4.37M
5
GAM
Gotham Asset Management
New York
+$4.34M

Top Sellers

Rank Fund Capital Flow
1
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management
California
-$17M
2
HA
Heartland Advisors
Wisconsin
-$12M
3
AL
AJO LP
Pennsylvania
-$6.81M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$3.29M
5
KIM
Kestrel Investment Management
California
-$2.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
26
AQR Capital Management
Connecticut
$6.28M -$878K -48,294 -14%
Goldman Sachs
27
Goldman Sachs
New York
$6.07M +$1.16M +63,863 +29%
Norges Bank
28
Norges Bank
Norway
$5.94M – – –
Geode Capital Management
29
Geode Capital Management
Massachusetts
$5.85M +$1.03M +56,769 +26%
QBFM
30
QS Batterymarch Financial Management
New York
$5.67M -$681K -37,460 -12%
Allianz Asset Management
31
Allianz Asset Management
Germany
$5.57M +$162K +8,891 +4%
Invesco
32
Invesco
Georgia
$5.48M +$1.72M +94,890 +59%
Boston Partners
33
Boston Partners
Massachusetts
$5.13M -$1.01M -55,771 -19%
Millennium Management
34
Millennium Management
New York
$4.65M +$3.36M +184,882 +591%
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$4.58M +$2.66M +146,225 +218%
OAM
36
Oxford Asset Management
United Kingdom
$4.26M +$259K +14,243 +8%
First Trust Advisors
37
First Trust Advisors
Illinois
$4.21M +$760K +41,806 +27%
Prudential Financial
38
Prudential Financial
New Jersey
$4.06M +$247K +13,569 +8%
PAM
39
Panagora Asset Management
Massachusetts
$3.96M +$358K +19,685 +12%
PPA
40
Parametric Portfolio Associates
Washington
$3.93M +$419K +23,054 +14%
Principal Financial Group
41
Principal Financial Group
Iowa
$3.69M -$72.9K -4,009 -2%
PCA
42
Personal Capital Advisors
California
$3.53M +$2.98M +164,121 New
BIM
43
Bogle Investment Management
Massachusetts
$3.46M +$2.92M +160,746 New
LG
44
Leuthold Group
Minnesota
$3.29M +$483K +26,549 +21%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$2.99M +$117K +6,445 +5%
TCIM
46
TIAA CREF Investment Management
New York
$2.98M -$73.6K -4,050 -3%
Charles Schwab
47
Charles Schwab
California
$2.9M -$881K -48,452 -26%
Connor, Clark & Lunn Investment Management (CC&L)
48
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.8M +$1.77M +97,200 +384%
Two Sigma Investments
49
Two Sigma Investments
New York
$2.54M +$2.15M +118,303 New
NAP
50
New Amsterdam Partners
New York
$2.51M -$50.5K -2,777 -2%
1
2
3 4 5

PMC Hedge Fund Activity: Q4 2013 in Review

158 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in PharMerica Corporation (PMC) for Q4 2013, worth a combined $627M — up 67% from $375M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new PMC positions and 14 closed out — a net gain of 11 holders — while 53 added to existing stakes and 59 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $15.8M. The largest seller was Hotchkis & Wiley Capital Management, exiting entirely with an estimated $17M sold.

  • 158 institutional investors held PharMerica Corporation (PMC) as of Q4 2013, up from 147 in Q3 2013.
  • Funds reported $627M of PharMerica Corporation stock for Q4 2013, up 67% quarter-over-quarter.
  • 25 funds opened new PharMerica Corporation positions in Q4 2013 and 14 closed out, a net change of +11 holders.
  • The largest PharMerica Corporation buyer in Q4 2013 was Fidelity Investments, an estimated $15.8M added.
  • The largest PharMerica Corporation seller in Q4 2013 was Hotchkis & Wiley Capital Management, an estimated $17M sold.

Based on aggregated 13F filings for Q4 2013.